Please login to the form below

Not currently logged in
Email:
Password:

I-Mab

This page shows the latest I-Mab news and features for those working in and with pharma, biotech and healthcare.

AbbVie signs immunotherapy pact with I-Mab worth $2bn

AbbVie signs immunotherapy pact with I-Mab worth $2bn

In addition, I-Mab will receive a milestone payment of $20m based on results from phase 1 studies of the drug. ... If the drug proves effective and wins regulatory approval, AbbVie will also pay I-Mab tiered royalties from low-to-mid teen percentages on

Latest news

  • Morphosys’ Darzalex patent challenge hits a hurdle Morphosys’ Darzalex patent challenge hits a hurdle

    China in the first quarter of this year with the help of partner I-Mab, which licensed rights to the drug in mainland China, Hong Kong, Macau and Taiwan in November

  • Biologics at forefront

    anti-IL 21 MAb (autoimmune/inflammatory disease)   . Preclinical . 181.5. Intercell/GSK Biologicals . patch-based vaccines  .  . ... 5m at the start of phase I studies on the IL-21 MAb, plus royalties on net sales.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Acquisition - company. $600. Boehringer Ingelheim/ AbbVie. BI-655066: anti-IL-23 MAb in Phase III for psoriasis and other autoimmune disorders; and BI-655064: anti-CD-40 MAb in Phase I. ... Acquisition – company. $200. TaiMed/ Theratechnologies.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics